Astera Labs
- Market cap
- 66.31B
- P/E (TTM)i
- 188.30
- P/Bi
- 38.43
- EPSi
- 1.22
- Div yieldi
- 0.00%
- 52W posi
- 71%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Astera Labs closed at 382.25, down 1.94%. At current prices, the business is worth about 66.31B, the #366 most valuable US-listed company we track. Trading at a P/E of 175.35, the stock is 209% above its own five-year norm of 56.75. The 16 analysts covering the stock are, on balance, at Buy, targeting an average of 416.60 (+9%). The shares sit 71% of the way up their 52-week range of 97.89 to 499.48.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 11% of the universe, above its 200-day average.
- Signal has read BUY for 2 weeks.
- Recent price momentum is +40.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 5.0% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation D-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 178.5x | Better than 3% |
| Forward P/E | 78.0x | Better than 4% |
| Price / Sales | 51.4x | Better than 3% |
| P/E vs own 5-yr range | 72nd pctl | Better than 36% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 75.7% | Better than 88% |
| Operating margin | 20.3% | Better than 66% |
| Net margin | 25.7% | Better than 84% |
| Return on equity | 18.8% | Better than 64% |
| Return on invested capital | 15.9% | Better than 75% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -5.4% | Better than 40% |
| 6-month return | 204.5% | Better than 99% |
| 12-month return (ex latest month) | 40.6% | Better than 75% |
| Distance below 52-week high | 27.5% | Better than 32% |
Financial Health A+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 10.2x | Better than 97% |
| Debt to assets | 0.3% | Better than 99% |
| Free cash flow / net income | 128.6% | Better than 62% |
Analyst View C+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 75.0% | Better than 51% |
| Upside to average target | 15.0% | Better than 27% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 389.80
- Open
- 376.00
- Day range
- 360.22 - 388.14
- Avg price
- 376.88
- Volume
- 5.03M
- Turnover
- 1.90B
- Turnover ratei
- 3.22%
- Volume ratioi
- 1.18
- Amplitudei
- 7.16%
- 52-week rangei
- 97.89 - 499.48
Valuation
- P/Ei
- 313.32
- P/E (TTM)i
- 188.30
- P/Bi
- 38.43
- EPSi
- 1.22
- Book value / shi
- 9.95
- Net profit
- 211.65M
- Net assets
- 1.73B
Share structure
- Market cap
- 66.31B
- Float capi
- 59.62B
- Shares out
- 173.49M
- Float sharesi
- 155.98M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2024-03-20
23.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-87.02M net over the window
Short interest
- Shares short
- 8.69M
- % of floati
- 5.01%
- Days to coveri
- 2.24
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Astera Labs (ALAB)?
Astera Labs last traded at 382.25. The quote on this page refreshes every few seconds while US markets are open.
What is Astera Labs's market cap?
About 66.31B.
What is the P/E ratio of Astera Labs?
The trailing twelve-month P/E is 188.30, above its own 5-year average of 56.75 — toward the top of its historical range (71.54% percentile). See the Valuation tab for the full history.
Does Astera Labs pay a dividend?
Astera Labs does not currently pay a regular dividend.
Is Astera Labs a buy according to analysts?
The consensus of 16 analysts is a Buy rating, with an average 12-month price target of 416.60, which implies 9.0% upside from the current price. This is not investment advice.
What is Astera Labs's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Astera Labs a B (Buy). Twelve-month momentum in the top 11% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 08:19:52 · For reference only, not investment advice and not tailored to your situation.